19-15162570-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000435.3(NOTCH3):​c.5816-8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.893 in 1,612,158 control chromosomes in the GnomAD database, including 644,165 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.90 ( 62118 hom., cov: 31)
Exomes 𝑓: 0.89 ( 582047 hom. )

Consequence

NOTCH3
NM_000435.3 splice_region, intron

Scores

2
Splicing: ADA: 0.000005957
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.364

Publications

18 publications found
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
NOTCH3 Gene-Disease associations (from GenCC):
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral meningocele syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myofibromatosis, infantile, 2
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-15162570-A-G is Benign according to our data. Variant chr19-15162570-A-G is described in ClinVar as Benign. ClinVar VariationId is 256145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.966 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH3NM_000435.3 linkc.5816-8T>C splice_region_variant, intron_variant Intron 31 of 32 ENST00000263388.7 NP_000426.2
NOTCH3XM_005259924.5 linkc.5660-8T>C splice_region_variant, intron_variant Intron 30 of 31 XP_005259981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH3ENST00000263388.7 linkc.5816-8T>C splice_region_variant, intron_variant Intron 31 of 32 1 NM_000435.3 ENSP00000263388.1
NOTCH3ENST00000597756.1 linkc.329-8T>C splice_region_variant, intron_variant Intron 2 of 2 2 ENSP00000468879.1
NOTCH3ENST00000595514.1 linkn.*24-8T>C splice_region_variant, intron_variant Intron 3 of 4 3 ENSP00000470661.1

Frequencies

GnomAD3 genomes
AF:
0.901
AC:
137041
AN:
152068
Hom.:
62067
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.974
Gnomad AMI
AF:
0.885
Gnomad AMR
AF:
0.781
Gnomad ASJ
AF:
0.878
Gnomad EAS
AF:
0.805
Gnomad SAS
AF:
0.852
Gnomad FIN
AF:
0.884
Gnomad MID
AF:
0.886
Gnomad NFE
AF:
0.899
Gnomad OTH
AF:
0.878
GnomAD2 exomes
AF:
0.864
AC:
216238
AN:
250336
AF XY:
0.866
show subpopulations
Gnomad AFR exome
AF:
0.977
Gnomad AMR exome
AF:
0.715
Gnomad ASJ exome
AF:
0.872
Gnomad EAS exome
AF:
0.800
Gnomad FIN exome
AF:
0.887
Gnomad NFE exome
AF:
0.900
Gnomad OTH exome
AF:
0.862
GnomAD4 exome
AF:
0.892
AC:
1302111
AN:
1459972
Hom.:
582047
Cov.:
34
AF XY:
0.891
AC XY:
646816
AN XY:
726344
show subpopulations
African (AFR)
AF:
0.979
AC:
32739
AN:
33444
American (AMR)
AF:
0.722
AC:
32186
AN:
44586
Ashkenazi Jewish (ASJ)
AF:
0.872
AC:
22774
AN:
26124
East Asian (EAS)
AF:
0.827
AC:
32812
AN:
39690
South Asian (SAS)
AF:
0.853
AC:
73505
AN:
86152
European-Finnish (FIN)
AF:
0.887
AC:
47200
AN:
53204
Middle Eastern (MID)
AF:
0.847
AC:
4869
AN:
5748
European-Non Finnish (NFE)
AF:
0.903
AC:
1003011
AN:
1110702
Other (OTH)
AF:
0.879
AC:
53015
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
6535
13070
19604
26139
32674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21396
42792
64188
85584
106980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.901
AC:
137150
AN:
152186
Hom.:
62118
Cov.:
31
AF XY:
0.897
AC XY:
66714
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.974
AC:
40475
AN:
41542
American (AMR)
AF:
0.781
AC:
11928
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.878
AC:
3047
AN:
3472
East Asian (EAS)
AF:
0.806
AC:
4148
AN:
5148
South Asian (SAS)
AF:
0.851
AC:
4111
AN:
4828
European-Finnish (FIN)
AF:
0.884
AC:
9357
AN:
10590
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.899
AC:
61161
AN:
68014
Other (OTH)
AF:
0.879
AC:
1858
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
661
1322
1983
2644
3305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.905
Hom.:
26237
Bravo
AF:
0.895
Asia WGS
AF:
0.850
AC:
2956
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Lateral meningocele syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.3
DANN
Benign
0.59
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000060
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4809030; hg19: chr19-15273381; API